Indian pharmaceutical company has a history of selling substandard drugs for child deaths in Gambia

India's Maiden Pharmaceuticals' Cough Syrup Has Killed 66 Children In Gambia


The company has been in the limelight since Maiden Pharmaceuticals came under the World Health Organization (WHO) scanner after it flagged four cough syrups made in India and exported to The Gambia, which caused the deaths of 66 children. Countless violations of regulations in the past have been allowed to operate with impunity.


Four cough syrups found to contain dangerous levels of ethylene glycol and diethylene glycol, which have led to kidney damage, were licensed for export and sale in the Gambia only by the state drug regulator, Indian government reports said. Quality and safety parameters of drugs have failed over the years in several Indian states.


The World Health Organization issued an alert on October 5, advising regulatory authorities and the public to stop consuming four medicinal products manufactured by Maiden Pharmaceuticals that it found to be of substandard quality.


WHO identified these products as Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup, all manufactured by Maiden Pharmaceuticals based in Haryana, India.


The drugs reportedly killed 66 children in The Gambia.


According to the World Health Organization, laboratory analysis of each of these products confirmed that they contained unacceptable levels of diethylene glycol and ethylene glycol as contaminants.



A panel of central and state drug regulators has started investigating the matter and samples of the products have been taken for testing.






Video in Tamil






Post a Comment

Thanks for Reading..♥Keep Supporting..🙏

أحدث أقدم